文献速递乳房整形与再造美容整形创面修复

氨甲环酸在乳房与身体塑形手术中的系统综述与荟萃分析

Tranexamic Acid in Body Contouring Surgery: A Systematic Review and Meta-Analysis.
PubMed 文献 · Aesthet Surg J · 2025-01-01

该荟萃分析检索PubMed,纳入13项在标准乳房再造和身体塑形手术中使用氨甲环酸(TXA)的研究,采用Mantel-Haenszel随机效应模型计算比值比(OR)及95%CI。结果显示TXA组血肿风险显著降低(OR=0.37;

要点

  • 静脉TXA可能降低乳房与身体塑形手术的血肿和伤口愈合并发症风险。

核心结论

  • 在乳房与身体塑形手术中,静脉TXA可能降低血肿和伤口愈合并发症风险,局部TXA可能降低感染风险。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed,纳入13项在标准乳房再造和身体塑形手术中使用TXA的研究。
  • 采用Mantel-Haenszel随机效应模型计算二分类结局的OR及95%CI,并设全身(IV)、局部或IV联合局部TXA亚组。

主要发现

  • 伤口愈合问题和血清肿形成无显著差异。

临床怎么用

  • 在乳房与身体塑形手术中可考虑静脉TXA以降低血肿和伤口愈合并发症风险。
  • 局部应用TXA可能有助于降低感染风险。

局限性

  • 证据等级为3级(治疗性)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Breast and body contouring procedures are plastic surgery's most popular and effective interventions. Although these procedures are generally safe, they are not without risks and complications. Antifibrinolytic drugs such as tranexamic acid (TXA) have been used as an adjunct to improve outcomes. The authors of this meta-analysis explore the impact of TXA on complications in breast and body contouring procedures. They searched PubMed (US National Library of Medicine, Bethesda, MD) for studies that used TXA in standard breast reconstruction and body contouring procedures. They then performed a meta-analysis on the following complications: hematoma, seroma, infection, and wound-healing complications. A Mantel-Haenszel method random-effects model was used to calculate the odds ratio (OR) within and a 95% CI for dichotomous outcomes. Subgroups were created for studies that utilized systemic (IV), topical or concurrent IV, and topical TXA administration. A total of 13 studies were selected and included in the analysis. There was a significant lower risk of hematoma (OR = 0.37; 95% CI = 0.18-077; P = .008) in the TXA cohort. There were no significant differences observed in terms of wound-healing issues or seroma formation. The subgroup analysis of this study demonstrated significantly decreased risks of infection (OR = 0.41; 95% CI = 0.22-077; P = .005) in the topical TXA cohort. In breast and body contouring procedures, the risk of hematoma and wound-healing complications can potentially be reduced by IV TXA administration. The infection risk can be potentially reduced by topical TXA administration. Level of Evidence: 3 (Therapeutic).

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Fijany AJ, Holan CA, Troia T, et al. Tranexamic Acid in Body Contouring Surgery: A Systematic Review and Meta-Analysis. Aesthet Surg J. 2025. PMID: 40509914. doi:10.1093/asj/sjaf112

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。